Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium

Abstract Despite increasing evidence suggesting that angiotensin II type 2 receptor (AT2R) may regulate tissue inflammation, no study has yet analyzed its possible implication in rheumatoid arthritis (RA) synovitis. In this study, we investigated the expression and function of AT2R in synovial tissu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Riccardo Terenzi, Mirko Manetti, Irene Rosa, Eloisa Romano, Felice Galluccio, Serena Guiducci, Lidia Ibba-Manneschi, Marco Matucci-Cerinic
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/42aabc8ad58c42949f9cf7a5099845f7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:42aabc8ad58c42949f9cf7a5099845f7
record_format dspace
spelling oai:doaj.org-article:42aabc8ad58c42949f9cf7a5099845f72021-12-02T15:05:47ZAngiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium10.1038/s41598-017-13746-w2045-2322https://doaj.org/article/42aabc8ad58c42949f9cf7a5099845f72017-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-13746-whttps://doaj.org/toc/2045-2322Abstract Despite increasing evidence suggesting that angiotensin II type 2 receptor (AT2R) may regulate tissue inflammation, no study has yet analyzed its possible implication in rheumatoid arthritis (RA) synovitis. In this study, we investigated the expression and function of AT2R in synovial tissue and cultured fibroblast-like synoviocytes (FLS) from RA patients. AT2R expression was strongly increased in RA compared with osteoarthritis (OA) synovium, as well as in in cultured RA-FLS respect to OA-FLS and healthy FLS. Treatment with pro-inflammatory cytokines was able not only to boost AT2R expression in RA-FLS and OA-FLS, but also to induce its de novo expression in healthy FLS. The stimulation of AT2R with the specific agonist CGP42112A significantly reduced gene expression of interleukin (IL)-1β and IL-6 and activation of NF-κB in RA-FLS, while opposite effects were elicited by AT2R small interfering RNA. Moreover, AT2R agonism efficiently decreased RA-FLS proliferation and migration either at baseline or under pro-inflammatory cytokine challenge. In conclusion, AT2R is strongly expressed in key effector cells of rheumatoid synovitis, namely RA-FLS, and the activation of AT2R with a specific agonist may effectively dampen their pro-inflammatory and aggressive behavior. AT2R agonism might represent a novel therapeutic strategy for patients with RA.Riccardo TerenziMirko ManettiIrene RosaEloisa RomanoFelice GalluccioSerena GuiducciLidia Ibba-ManneschiMarco Matucci-CerinicNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Riccardo Terenzi
Mirko Manetti
Irene Rosa
Eloisa Romano
Felice Galluccio
Serena Guiducci
Lidia Ibba-Manneschi
Marco Matucci-Cerinic
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium
description Abstract Despite increasing evidence suggesting that angiotensin II type 2 receptor (AT2R) may regulate tissue inflammation, no study has yet analyzed its possible implication in rheumatoid arthritis (RA) synovitis. In this study, we investigated the expression and function of AT2R in synovial tissue and cultured fibroblast-like synoviocytes (FLS) from RA patients. AT2R expression was strongly increased in RA compared with osteoarthritis (OA) synovium, as well as in in cultured RA-FLS respect to OA-FLS and healthy FLS. Treatment with pro-inflammatory cytokines was able not only to boost AT2R expression in RA-FLS and OA-FLS, but also to induce its de novo expression in healthy FLS. The stimulation of AT2R with the specific agonist CGP42112A significantly reduced gene expression of interleukin (IL)-1β and IL-6 and activation of NF-κB in RA-FLS, while opposite effects were elicited by AT2R small interfering RNA. Moreover, AT2R agonism efficiently decreased RA-FLS proliferation and migration either at baseline or under pro-inflammatory cytokine challenge. In conclusion, AT2R is strongly expressed in key effector cells of rheumatoid synovitis, namely RA-FLS, and the activation of AT2R with a specific agonist may effectively dampen their pro-inflammatory and aggressive behavior. AT2R agonism might represent a novel therapeutic strategy for patients with RA.
format article
author Riccardo Terenzi
Mirko Manetti
Irene Rosa
Eloisa Romano
Felice Galluccio
Serena Guiducci
Lidia Ibba-Manneschi
Marco Matucci-Cerinic
author_facet Riccardo Terenzi
Mirko Manetti
Irene Rosa
Eloisa Romano
Felice Galluccio
Serena Guiducci
Lidia Ibba-Manneschi
Marco Matucci-Cerinic
author_sort Riccardo Terenzi
title Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium
title_short Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium
title_full Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium
title_fullStr Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium
title_full_unstemmed Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium
title_sort angiotensin ii type 2 receptor (at2r) as a novel modulator of inflammation in rheumatoid arthritis synovium
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/42aabc8ad58c42949f9cf7a5099845f7
work_keys_str_mv AT riccardoterenzi angiotensiniitype2receptorat2rasanovelmodulatorofinflammationinrheumatoidarthritissynovium
AT mirkomanetti angiotensiniitype2receptorat2rasanovelmodulatorofinflammationinrheumatoidarthritissynovium
AT irenerosa angiotensiniitype2receptorat2rasanovelmodulatorofinflammationinrheumatoidarthritissynovium
AT eloisaromano angiotensiniitype2receptorat2rasanovelmodulatorofinflammationinrheumatoidarthritissynovium
AT felicegalluccio angiotensiniitype2receptorat2rasanovelmodulatorofinflammationinrheumatoidarthritissynovium
AT serenaguiducci angiotensiniitype2receptorat2rasanovelmodulatorofinflammationinrheumatoidarthritissynovium
AT lidiaibbamanneschi angiotensiniitype2receptorat2rasanovelmodulatorofinflammationinrheumatoidarthritissynovium
AT marcomatuccicerinic angiotensiniitype2receptorat2rasanovelmodulatorofinflammationinrheumatoidarthritissynovium
_version_ 1718388699137310720